LFB Biomanufacturing
Clara Rouquairol has a strong background in biotechnology and biomanufacturing, currently serving as a Technicienne référente USP at LFB Biomanufacturing since August 2022. Previously, Clara worked as a Technicienne de laboratoire R&D at Genoscience Pharma during two separate periods in 2020 and 2021, and also gained experience as a Production Technician at HalioDx in 2018 to 2019. Earlier roles include a Laboratory Technician position at INRA French National Institute for Agricultural Research and another role as a Laboratory Technician at LFB Biomanufacturing. Clara holds a Master's degree in Biologie Integrative et Physiologie, alongside a Licence in Biologie cellulaire, both obtained from Aix-Marseille University, and a Brevet de technicien supérieur in Biotechnologies from Lycee Albert Camus.
This person is not in any offices
LFB Biomanufacturing
LFB Biomanufacturing is an expert CDMO in the development and manufacture of recombinant proteins via cell culture, with specific know-how in the area of monoclonal antibodies (mAbs). LFB Biomanufacturing supplies a full range of bioproduction services, from the development of cell lines to the manufacturing clinical and commercial batches of active substances from biological products up to multiple pool of 2000L Cell Culture production capacities using Disposable Bioreactors Technology and exclusively Single-Use systems. The Alès site is regulary inspected by Customers as well as Health Agencies, including French-ANSM and US-FDA. LFB Biomanufacturing is subsidiary of the LFB Group.